Rani Therapeutics Holdings, Inc.
RANI
$1.05
-$0.05-4.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.31M | -5.41M | -6.69M | -7.26M | -8.95M |
| Total Depreciation and Amortization | 186.00K | 223.00K | 240.00K | 251.00K | 266.00K |
| Total Amortization of Deferred Charges | 33.00K | 58.00K | 58.00K | 58.00K | 58.00K |
| Total Other Non-Cash Items | 4.41M | 328.00K | -618.00K | -1.22M | 1.10M |
| Change in Net Operating Assets | 5.97M | -260.00K | 1.22M | 28.00K | -1.13M |
| Cash from Operations | 294.00K | -5.06M | -5.80M | -8.15M | -8.66M |
| Capital Expenditure | 0.00 | 0.00 | -37.00K | -51.00K | -31.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.97M | 0.00 | 5.75M | 18.28M | 2.55M |
| Cash from Investing | -30.97M | 0.00 | 5.71M | 18.23M | 2.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.47M | -3.75M | -3.75M | -3.75M | -3.75M |
| Issuance of Common Stock | 112.97M | 2.94M | 3.95M | 42.00K | 10.00M |
| Repurchase of Common Stock | -21.00K | -7.00K | -8.00K | -23.00K | -9.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.28M | -189.00K | -- | -- | -621.00K |
| Cash from Financing | 44.85M | -1.01M | 188.00K | -3.73M | 5.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.17M | -6.07M | 105.00K | 6.35M | -515.00K |